Mangoceuticals shares surge 104.07% premarket after announcing $2.5M registered direct offering and private placement.

Mangoceuticals surged 104.07% in premarket trading following the announcement of a $2.5 million registered direct offering and private placements priced at the market under Nasdaq rules. The equity raise, disclosed by the company on quiverquant.com and globenewswire.com, signals investor confidence in its capital-raising strategy and operational flexibility. While prior insider selling by the CFO and director had raised concerns, the recent funding news overshadowed those developments, suggesting renewed optimism about the firm’s ability to execute growth initiatives. The move aligns with Mangoceuticals’ ongoing efforts to expand its product portfolio and partnerships, including recent entries into weight-management programs and the wellness pouch market.